In industry we don't bother to "adopt" the goods of labs as described by Caryn Evilia.1 Rather, we are "... self-empowered to reallocate underperforming corporate assets in an effort to maximize shareholder value ..."
"
Rhodes Technologies Coventry, RI
Interested in reading more?
Become a Member of
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
